Ardelyx to Webcast Virtual Analyst Day
November 06, 2020 at 08:00 AM EST
FREMONT, Calif., Nov. 6, 2020 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases, today announced that it will hold a virtual Analyst Day on Thursday, November 12, 2020, from 9:30 a.m. to 12:00 p.m. ET. This year's event will focus on the company's launch and commercialization plans in anticipation of the potential approval of tenapanor for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Additionally, the company will review its pipeline therapeutic for hyperkalemia.
The management team will be joined by:
A live webcast of the event will be available on the Ardelyx website via the Events and Presentations page under the investor relations section at https://ir.ardelyx.com/events-and-presentations.
About Ardelyx, Inc.
View original content to download multimedia:http://www.prnewswire.com/news-releases/ardelyx-to-webcast-virtual-analyst-day-301167749.html